Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002650 · ClinicalTrials.gov registry record · Phase 2
High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed
A Phase 2 study, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT00002650 is a Phase 2 study that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 80 participants.
The verdict
NCT00002650, a Phase 2 study, has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of folic acid may be an effective way to prevent colorectal cancer in patients with polyps that have been surgically removed. PURPOSE: Randomized phase II trial to study the effectiveness of high-dose folic acid in preventing colorectal cancer in patients who have had polyps surgically removed within 18 months of the trial.
Interventions
- DIETARY_SUPPLEMENT folic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 1995-06-12 |
| Est. Completion | 2009-05-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002650
The ClinicalTrials.gov registry entry for NCT00002650 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which folic acid is the first listed.
NCT00002650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002650 about?
NCT00002650 is a clinical study titled "High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed". RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of folic acid may be an effective way to prevent colorectal cancer in patients with polyps that have been surgically removed. PURPOSE: Randomized phase II trial to study...
What is the current status of trial NCT00002650?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 1995-06-12. Estimated completion is 2009-05-01.
What interventions are being tested in trial NCT00002650?
The interventions under investigation include: folic acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00002650?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.